Integrated Care (IC) is a perfect fit for people with diabetes. Fundus examination (FE) is a disease marker for diabetologists and identifies potentially blinding complications (Diabetic Retinopathy, DR). In our Diabetes Clinic (DC) in Pescara, Italy, FE is possibly provided with telemedicine in same day as other exams, avoiding it to be a standalone clinical one; images taken with a retinal digital camera are graded by a remote ophthalmologist within a shared Electronic Health Record (EHR), immediately readable by other stakeholders; a dedicated care path to the Eye Clinic, University of Chieti-Pescara is provided for urgent cases. Personnel’s worktime shortening allows gaining time for ophthalmologists’ eye examinations in outpatient settings and other stakeholders’ work in the DC. The need for a DR digital screening system is growing worldwide: our experience confirms the ease of implementation, and the advantage of sharing clinical data with all stakeholders when working within an EHR, aiming to optimize an IC effective system.
SolomonSDChewEDuhEJ, et al. Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care2017; 40(3): 412–418.
4.
World Health Organization. Use of Glycated haemoglobin (HbA1c) in the diagnosis of Diabetes Mellitus. Abbreviated report of a WHO consultation, https://apps.who.int/iris/handle/10665/70523 (2011, accessed 5 January 2021).
Società Italiana di Medicina Specialistica – Sindacato Unico Medicina Ambulatoriale Italiana. Tempi Medi di Attività, Modalità di Esecuzione, Nomenclatore delle Prestazioni Specialistiche Ambulatoriali Territoriali. 1st ed. Italy: Pubblicazioni SUMAI, 2006.
13.
Centers for Disease Control, National Center for Chronic Disease Prevention and Health Promotion, cdc.gov/visionhealth/pdf/factsheet.pdf (2011, accessed 25 January 2021).
14.
ZhangXLowSKumariN, et al. Direct medical cost associated with diabetic retinopathy severity in type 2 diabetes in Singapore. PLoS One2017; 12(7): e0180949.
15.
SchmierJKCovertDWLauEC, et al. Medicare expenditures associated with diabetes and diabetic retinopathy. Retina2009; 29(2): 199–206.
16.
The Lancet Diabetes & Endocrinology. COVID-19 and diabetes: a co-conspiracy?Lancet Diabetes Endocrinol2020; 8(10): 801.
European Commission – Action Group B3. European innovation partnership on active and healthy ageing. Replicating and tutoring integrated care for chronic diseases, including remote monitoring at regional level. A compilation of good practices. 2nd ed.2013. www.ec.europa.eu/eip/ageing/actiongroup/index/b3/key-documents_en.html (accessed 27th January 2021).
JudahGVlaevIGunnL, et al. Incentives in diabetic eye assessment by screening (IDEAS): study protocol of a three-arm randomized controlled trial using financial incentives to increase screening uptake in London. BMC Ophthalmol2016; 16(16): 28.
26.
XiaoBLiaoQLiY, et al. Validation of handheld fundus camera with mydriasis for retinal imaging of diabetic retinopathy screening in China: a prospective comparison study. BMJ Open2020; 10(10): e040196.
27.
LiuYZupanNJSwearingenR, et al. Identification of barriers, facilitators and system-based implementation strategies to increase teleophthalmology use for diabetic eye screening in a rural US primary care clinic: a qualitative study. BMJ Open2019; 9: e022594.
MastropasquaLPerilliRD’AloisioR, et al. Why miss the chance? Incidental findings while telescreening for diabetic retinopathy. Ophthalmic Epidemiol2020; 27(4): 237–245.
ParkHCLeeYKChoA, et al. Diabetic retinopathy is a prognostic factor for progression of chronic kidney disease in the patients with type 2 diabetes mellitus. PLoS One2019; 14(7): e0220506.
32.
CheungNWangJJKleinR, et al. Diabetic retinopathy and the risk of coronary heart disease. The atherosclerosis risk in communities study. Diabetes Care2007; 30(7): 1742–1746.
33.
SabanayagamCCheeMLBanuR, et al. Association of diabetic retinopathy and diabetic kidney disease with all-cause and cardiovascular mortality in a multiethnic Asian population. JAMA Netw Open2019; 2(3): e191540.
HortonMBBradyCJCavalleranoJ, et al. Practice guidelines for ocular telehealth-diabetic retinopathy, third edition. Telemed J E Health2020; 26(4): 495–543.
36.
Schmidt-ErfurthUSadeghipourAGerendasBS, et al. Artificial intelligence in Retina. Prog Retin Eye Res2018; 67: 1–29.
37.
BellemoVLimGRimTH, et al. Artificial intelligence screening for diabetic retinopathy: the real-world emerging application. Curr Diab Rep2019; 19: 72.
38.
XieYNguyenQDHamzahH, et al. Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study. Lancet Digit Health2020; 2: e240–e249.
39.
GBD 2019 Blindness and Vision Impairment Collaborators and Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the Global Burden of disease study. Lancet2021; 9: e144–e160.
